• Info
  • Insider Ownership

Insider Trading & Ownership of Thomas A. Mccourt

Location
Boston, MA
Summary
The estimated net worth of Thomas A. Mccourt is at least $9,340,986 dollars as of 12 Mar 2026. Thomas A. Mccourt is the Chief Executive Officer, Director of IRONWOOD PHARMACEUTICALS INC and owns shares of IRONWOOD PHARMACEUTICALS INC (IRWD) stock worth about $9.29M. Thomas A. Mccourt is the Director of PLIANT THERAPEUTICS, INC. and owns shares of PLIANT THERAPEUTICS, INC. (PLRX) stock worth about $55.7K.
Signature
/s/ Amir Vitale, Attorney-in-Fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Thomas A. Mccourt and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.

Quick Takeaways

  • Thomas A. Mccourt has 3 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $9,340,986.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: IRONWOOD PHARMACEUTICALS INC ($9,285,317).
  • Past-year value change for that position: -$747,674.

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Thomas A. Mccourt

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
IRWD IRONWOOD PHARMACEUTICALS INC Chief Executive Officer, Director $9,285,317 -$747,674 -7.5% 10 Mar 2026
PLRX PLIANT THERAPEUTICS, INC. Director $55,669 05 Jun 2025
XLRN ACCELERON PHARMA INC Director 19 Nov 2021

Insider Transactions Reported by Thomas A. Mccourt:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.